Myeloproliferative Neoplasm, BCR-ABL1 Negative

Myeloproliferative Neoplasm, BCR-ABL1 Negative — Trials · CancerIndex

Clinical trials

Registered studies

333 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 50
Ph III recruiting: 7
Growth YoY: —
Industry share: 41%
Top sponsor: City of Hope Medical Center
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01962636	Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases	terminated	N/A	200	Masonic Cancer Center, University of MinnesotaOTHER	1	May 20, 2026	clinicaltrials
NCT03121599	18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms	terminated	N/A	3	Hamad Medical CorporationINDUSTRY	1	Aug 11, 2020	clinicaltrials